Verastem Oncology Announces Promotion of Dan Paterson to Chief Executive Officer
Position
Chief Executive Officer
Company
Verastem Oncology
NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that Dan Paterson, President and Chief Operating Officer, has been promoted to President and Chief Executive Officer . Brian Stuglik will retire from the CEO role and remain a member of the Board of Directors. These changes will be effective August 1, 2023, allowing for a smooth leadership transition.","Dan Paterson joined Verastem Oncology in 2011 and has served as Chief Operating Officer since 2014 and President since 2019
Quick answer
Verastem Oncology Announces Promotion of Dan Paterson to Chief Executive Officer (July 11, 2023). Verastem Oncology is based in Needham, Massachusetts, United States.
- Who is the new Chief Executive Officer at Verastem Oncology?
- Verastem Oncology named Dan Paterson Chief Executive Officer, announced July 11, 2023.
- What did Verastem Oncology announce on July 11, 2023?
- Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that Dan Paterson, President and Chief Operating Officer, has been promoted to President and Chief Executive Officer . Brian Stuglik will retire from the CEO role and remain a member of the Board of Directors.
- What does Verastem Oncology do?
- Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK...
- Where is Verastem Oncology based?
- Verastem Oncology is based in Needham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Arbutus (July 11, 2023), MBX Biosciences, Inc. (July 10, 2023), AbbVie Inc. (June 29, 2023) and EyePoint, Inc. (July 10, 2023) also announced leadership changes within 45 days of Verastem Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Arbutus Biopharma appoints Karen Sims as chief medical officer (NASDAQ:ABUS) | Seeking Alpha (July 11, 2023)
- MBX Biosciences Appoints Steven J. Prestrelski, Ph.D., (July 10, 2023)
- AbbVie Inc Appoints Robert A Michael as President and Chief Operating Officer Demonstrating Commitment to Strong Leadership and Continued Growth - Best Stocks (June 29, 2023)
- EyePoint Pharmaceuticals Announces Chief Executive Officer (July 10, 2023)
- Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer (July 13, 2023)
- Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer (July 25, 2023)
Who to call at Verastem Oncology, and when
A new leader at Verastem Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verastem Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verastem Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Verastem Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.